Lomax Ward
Founding Partner @ Luminous Ventures
London, United Kingdom
Lomax Ward is a seed investor at Luminous Ventures in London focused on Software and Information Technology. Max was previously a healthcare and life science investor at White Cloud Capital, making venture and growth capital investments in Europe and Asia across a range of indications, technologies and services. Having graduated from the University of Cambridge, Max started out as a corporate lawyer at Slaughter and May in London, Milan and Tokyo,sitting in the TMT and IP group. There he worked on, among other things, technology IPOs and M&A, giving him a taste for the commercial and investment side. His experience in intellectual property and regulation is particularly useful for the deep technology companies in which Luminous invests. Outside of the office, Max is often to be found trail running in the mountains or (where he can't get away) the Surrey Hills.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Lomax Ward invests in
Stages Lomax Ward invests in
Countries Lomax Ward invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 3 (43%)
- Information Technology 2 (29%)
- Artificial Intelligence 2 (29%)
- Legal 1 (14%)
- Advice 1 (14%)
Stage
- Seed 5 (71%)
- Pre-Seed 2 (29%)
Country
- United Kingdom 4 (57%)
- Poland 1 (14%)
- Ireland 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MixRift is a gaming company that specializes in designing and developing interactive and mixed-reality gaming experiences. | $1.5M / Pre-Seed / Aug 07, 2024 | ||
| Molecule One is an information technology based bio company. Their m1 platform spans the preclinical pipeline to maximize chemistry. Molecule One integrates artificial intelligence into a suite of tools to assist bench chemists, data scientists, and computational chemists. | $4.6M / Seed / Jun 01, 2021 | ||
| LGN is a developer of artificial perception technology used to balance and automatically connect the AI system to the sensor array. Its technology reduces capture and processing costs by automatically filtering data to only record and process edge cases and by transferring and storing data in a highly compressed form that enable industries with areduced chip cost and power consumption whilst allowing high-level autonomy on lower-cost commodity sensors. | $1.9M / Seed / Mar 23, 2021 | ||
| Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | $4.5M / Seed / Jun 14, 2020 | ||
| Optellum develops an imaging biomarker for smart lung cancer detection. Optellum’s vision is to redefine cancer care, by enabling every clinician, in every hospital, to manage their patients in the optimal way. They do that by providing end-end IT platform for personalized early diagnosis and therapy, based on the collective experience ofthousands of doctors pooled by machine learning applied to vast patient datasets. Their first suite of products targets management of patients at high risk of developing lung cancer – the world’s deadliest and commonest cancer – from early diagnosis through to treatment. Optellum comprises a team of award-winning medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision lab. Between us, they have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. They are backed by an Advisory Board comprising world-leading clinicians and experts in deep learning ; and Oxford's most prominent investors. They are building up their product development team – join their fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups (e.g. Mirada Solutions – acquired by Siemens). | $1.3M / Seed / Jul 16, 2019 | ||
| Your knowledgeable companion for everything after life. Whatever journey you’re on, you can trust Beyond to help you make the best decision. | $2.8M / Seed / Feb 15, 2018 | ||
| Your knowledgeable companion for everything after life. Whatever journey you’re on, you can trust Beyond to help you make the best decision. | $919.7K / Pre-Seed / Oct 11, 2016 |
Co-Investors
About Luminous Ventures
Luminous Ventures is a London-based VC fund investing in Deep Tech with a focus on the application of innovative technologies to healthcare, life science, nutrition, food and agriculture. Investing at Seed and Series A, Luminous has backed companies in Europe and North America.
Luminous Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alasdair Thong
Venture Partner
|
|||
|
Lomax Ward
Founding Partner
|
|||
|
Miao He
Associate
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Lomax Ward invest in?
Lomax Ward invests primarily in Software, Information Technology and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Lomax Ward?
Public channels for Lomax Ward include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Lomax Ward last invest?
The most recent investment recorded for Lomax Ward closed in Aug 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
